Clinical Trial Update: A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a buprenorphine transdermal patch for moderate to severe cancer pain in Chinese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Buprenorphine transdermal patch (buprenorphine)

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Cancer Pain | Phase 3 | Status: UNKNOWN